Two Sinopharm Omicron-Targeting Shots to Start Hong Kong Trials

A China National Pharmaceutical Group Co. unit said it’s received approval to start clinical trials in Hong Kong of two inactivated vaccines that target the omicron variant of coronavirus.
Read More